Neoplasms, Prostate

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

Investigation of Impact of AI on Prostate Cancer Workflow

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer

MRI/Ultrasound Fusion Guided Prostate Cryotherapy

Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

ARI103094-Follow-Up Study for REDUCE Study Subjects

Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA

Economic Analyses of the REDUCE Trial

Korean Practice Patterns for Screening PCA(Prostate Cancer)

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Quality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy

"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk

Sipuleucel-T Manufacturing Demonstration Study

ARTS - AVODART After Radical Therapy For Prostate Cancer Study